伏妥昔单抗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "伏妥昔单抗" in Chinese language version.

refsWebsite

Global rank Chinese rank

2web.archive.org

1^st place

1^st place

3,257^th place

3,896^th place

195^th place

179^th place

4^th place

5^th place

2^nd place

23^rd place

ama-assn.org

Statement On A Nonproprietary Name Adopted By The USAN Council - Futuximab （页面存档备份，存于互联网档案馆）, American Medical Association.

doi.org

Keir ST, Chandramohan V, Hemphill CD, Grandal MM, Melander MC, Pedersen MW, Horak ID, Kragh M, Desjardins A, Friedman HS, Bigner DD. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J. Neurooncol. July 2018, 138 (3): 489–498. PMC 5999169 . PMID 29564747. doi:10.1007/s11060-018-2832-6.

nih.gov

ncbi.nlm.nih.gov

Keir ST, Chandramohan V, Hemphill CD, Grandal MM, Melander MC, Pedersen MW, Horak ID, Kragh M, Desjardins A, Friedman HS, Bigner DD. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J. Neurooncol. July 2018, 138 (3): 489–498. PMC 5999169 . PMID 29564747. doi:10.1007/s11060-018-2832-6.

web.archive.org

Statement On A Nonproprietary Name Adopted By The USAN Council - Futuximab （页面存档备份，存于互联网档案馆）, American Medical Association.
World Health Organization. International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107 (PDF). WHO Drug Information. 2012, 26 (2) [2024-03-06]. （原始内容存档 (PDF)于2016-03-04）.

who.int

World Health Organization. International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107 (PDF). WHO Drug Information. 2012, 26 (2) [2024-03-06]. （原始内容存档 (PDF)于2016-03-04）.